{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T08:53:45Z","timestamp":1775465625436,"version":"3.50.1"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Folia Microbiol"],"DOI":"10.1007\/s12223-026-01469-3","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T06:53:20Z","timestamp":1775458400000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["mRNA vaccines against monkeypox: bridging immunoinformatics, structural vaccinology, and translational advances toward pan-orthopox immunity"],"prefix":"10.1007","author":[{"given":"Qamar","family":"Abuhassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamel","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Renuka","family":"Jyothi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pusparaj","family":"Samantsinghar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunjan","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aashna","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Turabek","family":"Boyqulov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"1469_CR1","doi-asserted-by":"crossref","unstructured":"(2014) McCollum AM and Damon IK (Clin Infect Dis 2013; 58:260-7). Clinical Infectious Diseases 58: 1792\u20131792","DOI":"10.1093\/cid\/ciu196"},{"key":"1469_CR2","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3390\/vaccines10091419","volume":"10","author":"A Abdelaal","year":"2022","unstructured":"Abdelaal A, Reda A, Lashin BI, Katamesh BE, Brakat AM, Al-Manaseer BM, Kaur S, Asija A, Patel NK, Basnyat S, Rabaan AA, Alhumaid S, Albayat H, Aljeldah M, Shammari BRA, Al-Najjar AH, Al-Jassem AK, AlShurbaji ST, Alshahrani FS, Alynbiawi A, Alfaraj ZH, Alfaraj DH, Aldawood AH, Sedhai YR, Mumbo V, Rodriguez-Morales AJ, Sah R (2022) Preventing the next pandemic: is live vaccine efficacious against monkeypox, or is there a need for killed virus and mRNA vaccines? Vaccines (Basel) 10:1419","journal-title":"Vaccines (Basel)"},{"key":"1469_CR3","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3390\/vaccines10091564","volume":"10","author":"SAH Abdi","year":"2022","unstructured":"Abdi SAH, Ali A, Sayed SF, Abutahir, Ali A, Alam P (2022) Multi-Epitope-Based Vaccine Candidate for Monkeypox: An In Silico Approach. Vaccines (Basel) 10:1564","journal-title":"Vaccines (Basel)"},{"key":"1469_CR4","doi-asserted-by":"publisher","first-page":"e28701","DOI":"10.1002\/jmv.28701","volume":"95","author":"D Aden","year":"2023","unstructured":"Aden D, Zaheer S, Kumar R, Ranga S (2023) Monkeypox (Mpox) outbreak during COVID-19 pandemic-Past and the future. J Med Virol 95:e28701","journal-title":"J Med Virol"},{"key":"1469_CR5","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12964-023-01376-x","volume":"21","author":"I Ahmad","year":"2023","unstructured":"Ahmad I, Fatemi SN, Ghaheri M, Rezvani A, Khezri DA, Natami M, Yasamineh S, Gholizadeh O, Bahmanyar Z (2023) An overview of the role of Niemann-pick C1 (NPC1) in viral infections and inhibition of viral infections through NPC1 inhibitor. Cell Commun Signal 21:352","journal-title":"Cell Commun Signal"},{"key":"1469_CR6","doi-asserted-by":"publisher","first-page":"e0342087","DOI":"10.1371\/journal.pone.0342087","volume":"21","author":"S Ahmad","year":"2026","unstructured":"Ahmad S, Aslam S, Khalid A (2026) Multi-epitope vaccine design against Monkeypox virus: An immunoinformatics approach. PLoS ONE 21:e0342087","journal-title":"PLoS ONE"},{"key":"1469_CR7","doi-asserted-by":"publisher","first-page":"6292","DOI":"10.1080\/07391102.2023.2233627","volume":"42","author":"S Aiman","year":"2024","unstructured":"Aiman S, Ali Y, Malik A, Alkholief M, Ahmad A, Akhtar S, Ali S, Khan A, Li C, Shams S (2024) Immunoinformatic-guided novel mRNA vaccine designing to elicit immunogenic responses against the endemic Monkeypox virus. J Biomol Struct Dyn 42:6292\u20136306","journal-title":"J Biomol Struct Dyn"},{"key":"1469_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s41182-024-00678-1","volume":"53","author":"A Akingbola","year":"2025","unstructured":"Akingbola A, Adegbesan CA, Adewole O, Idahor C, Odukoya T, Nwaeze E, Mayowa S, Abdullahi O, Mariaria PK (2025) Understanding the resurgence of mpox: key drivers and lessons from recent outbreaks in Africa. Trop Med Health 53:47","journal-title":"Trop Med Health"},{"key":"1469_CR9","doi-asserted-by":"publisher","first-page":"27861","DOI":"10.1038\/s41598-025-97192-z","volume":"15","author":"HJ Al-Ameer","year":"2025","unstructured":"Al-Ameer HJ, Zihlif M, Maslat A, Al-Awaida WJ, Ayyash AM, Imraish A, Al-Qinna N, Al-Omari T, Al-Qaisi T, Al-Zyoud W, Alzubi BT, Atoom AM, Fattash IA, Ambike S, Goh KW, Gushchina YS (2025) Targeting the proliferation of glioblastoma cells and enhancement of doxorubicin and temozolomide cytotoxicity through inhibition of PFKFB4 and HMOX1 genes with siRNAs. Sci Rep 15:27861","journal-title":"Sci Rep"},{"key":"1469_CR12","doi-asserted-by":"crossref","unstructured":"Al-Madhagi H, Kanawati A, Tahan Z (2024) Design of multi\u2010epitope chimeric vaccine against Monkeypox virus and SARS\u2010CoV\u20102: A vaccinomics perspective. J Cell Mol Med 28","DOI":"10.1111\/jcmm.18452"},{"key":"1469_CR10","doi-asserted-by":"publisher","first-page":"109108","DOI":"10.1016\/j.clim.2022.109108","volume":"243","author":"A Al-Musa","year":"2022","unstructured":"Al-Musa A, Chou J, LaBere B (2022) The resurgence of a neglected orthopoxvirus: Immunologic and clinical aspects of monkeypox virus infections over the past six decades. Clin Immunol 243:109108","journal-title":"Clin Immunol"},{"key":"1469_CR11","doi-asserted-by":"crossref","unstructured":"Al-Sahlawi F, Yaseen Mahmood Alabdali A, Chinnappan S, Al-Samydai A, Abdelkarim Maki MA (2024) Polymer-based nanoparticles in targeted cancer therapy: a review. J Appl Pharm Sci","DOI":"10.7324\/JAPS.2024.172227"},{"key":"1469_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/pharmaceutics13010045","volume":"13","author":"IM Alfagih","year":"2020","unstructured":"Alfagih IM, Aldosari B, AlQuadeib B, Almurshedi A, Alfagih MM (2020) Nanoparticles as Adjuvants and Nanodelivery Systems for mRNA-Based Vaccines. Pharmaceutics 13:45","journal-title":"Pharmaceutics"},{"key":"1469_CR14","doi-asserted-by":"crossref","unstructured":"Aram C, Barancheshmeh M, Alishvandi A, Khodabandehloo MH, Shirvani AH, Fotohi A, Ghezel MA, Borji A, Keikha M (2025a) Exploration of the protein and pharmacological landscape of monkeypox virus treatment: from entry point to end point. Mol Diversity 1\u201356","DOI":"10.1007\/s11030-025-11421-1"},{"key":"1469_CR15","doi-asserted-by":"publisher","first-page":"22610","DOI":"10.1038\/s41598-025-07433-4","volume":"15","author":"C Aram","year":"2025","unstructured":"Aram C, Karami L, Ranjbar MM (2025b) Development of a candidate mRNA vaccine based on Multi-Peptide targeting VP4 of rotavirus A: an immunoinformatics and molecular dynamics approach. Sci Rep 15:22610","journal-title":"Sci Rep"},{"key":"1469_CR16","doi-asserted-by":"crossref","unstructured":"Aram C, Saleki K, Mazloomi A, Barancheshmeh M, Rezaei N (2025c) Unraveling the M1R protein of monkeypox virus: An integrated structural bioinformatics, immunological profiling, and molecular dynamics simulation approach. Immunol Genet J","DOI":"10.18502\/igj.v8i4.20099"},{"key":"1469_CR17","doi-asserted-by":"crossref","unstructured":"Aram C, Saleki K, Mazloomi A, Rezaei N (2025d) Design of a trivalent DC-inducing mRNA vaccine against monkeypox, cowpox, and vaccinia viruses: A computational approach. Immunol Genet J","DOI":"10.18502\/igj.v8i4.20101"},{"key":"1469_CR18","doi-asserted-by":"publisher","first-page":"10489","DOI":"10.1128\/JVI.00304-15","volume":"89","author":"WD Arndt","year":"2015","unstructured":"Arndt WD, Cotsmire S, Trainor K, Harrington H, Hauns K, Kibler KV, Huynh TP, Jacobs BL (2015) Evasion of the Innate Immune Type I Interferon System by Monkeypox Virus. J Virol 89:10489\u201310499","journal-title":"J Virol"},{"key":"1469_CR19","doi-asserted-by":"publisher","first-page":"104623","DOI":"10.1016\/j.jddst.2023.104623","volume":"86","author":"M Assefi","year":"2023","unstructured":"Assefi M, Ataeinaeini M, Nazari A, Gholipour A, Vertiz-Osores JJ, Melody Calla-V\u00e1squez K, Zuhair T, Al-Naqeeb B, Hussein Jassim K, Kalajahi HG, Yasamineh S, Dadashpour M (2023) A state-of-the-art review on solid lipid nanoparticles as a nanovaccines delivery system. J Drug Deliv Sci Technol 86:104623","journal-title":"J Drug Deliv Sci Technol"},{"key":"1469_CR20","doi-asserted-by":"publisher","first-page":"1004804","DOI":"10.3389\/fimmu.2022.1004804","volume":"13","author":"S Aziz","year":"2022","unstructured":"Aziz S, Almajhdi FN, Waqas M, Ullah I, Salim MA, Khan NA, Ali A (2022) Contriving multi-epitope vaccine ensemble for monkeypox disease using an immunoinformatics approach. Front Immunol 13:1004804","journal-title":"Front Immunol"},{"key":"1469_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s00203-023-03480-5","volume":"205","author":"R Baghban","year":"2023","unstructured":"Baghban R, Ghasemian A, Mahmoodi S (2023) Nucleic acid-based vaccine platforms against the coronavirus disease 19 (COVID-19). Arch Microbiol 205:150","journal-title":"Arch Microbiol"},{"key":"1469_CR22","doi-asserted-by":"crossref","unstructured":"Banerji I, Bhattacharjee S, Mukherjee K, Bhattacharyya SN (2023) RNA Vaccines: The Evolution, Applications, and the Challenges Ahead. Nucleic Acid Biology and its Application in Human Diseases. Springer Nature Singapore, pp 349\u2013364","DOI":"10.1007\/978-981-19-8520-1_10"},{"key":"1469_CR23","doi-asserted-by":"crossref","unstructured":"Berry MT, MacIntyre CR, Cromer D, Hacker A, Davenport MP, Khoury DS (2025) Optimal deployment of limited vaccine supplies to control mpox outbreaks. npj Vaccines 10","DOI":"10.1038\/s41541-025-01289-5"},{"key":"1469_CR24","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.tips.2017.06.002","volume":"38","author":"SR Bonam","year":"2017","unstructured":"Bonam SR, Partidos CD, Halmuthur SKM, Muller S (2017) An Overview of Novel Adjuvants Designed for Improving Vaccine Efficacy. Trends Pharmacol Sci 38:771\u2013793","journal-title":"Trends Pharmacol Sci"},{"key":"1469_CR25","doi-asserted-by":"crossref","unstructured":"Bravo-V\u00e1zquez LA, Bernal-V\u00e1zquez D, Duttaroy AK, Paul S (2025) Current status of next-generation vaccines against mpox virus: a scoping review. Front Pharmacol 16","DOI":"10.3389\/fphar.2025.1533533"},{"key":"1469_CR26","doi-asserted-by":"publisher","first-page":"e0010141","DOI":"10.1371\/journal.pntd.0010141","volume":"16","author":"EM Bunge","year":"2022","unstructured":"Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, Steffen R (2022) The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Negl Trop Dis 16:e0010141","journal-title":"PLoS Negl Trop Dis"},{"key":"1469_CR27","doi-asserted-by":"crossref","unstructured":"Byrne J, Garcia-Leon A, Murphy A, Saini G, Banik I, Landay A, Luong Nguyen LB, Savinelli S, O\u2019Broin C, Horgan M, Kelly C, Mejia-Chew C, Sadlier C, de Barra E, O\u2019Halloran JA, Gautier V, Mallon PWG, Feeney ER (2025) Antibody responses are sustained 2 years post-Mpox infection but not following modified vaccinia ankara\u2013bavarian nordic vaccination. Open Forum Infect Dis 12","DOI":"10.1093\/ofid\/ofaf536"},{"key":"1469_CR28","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","volume":"20","author":"N Chaudhary","year":"2021","unstructured":"Chaudhary N, Weissman D, Whitehead KA (2021) mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat Rev Drug Discov 20:817\u2013838","journal-title":"Nat Rev Drug Discov"},{"key":"1469_CR29","first-page":"e26756","volume":"14","author":"AY Cheema","year":"2022","unstructured":"Cheema AY, Ogedegbe OJ, Munir M, Alugba G, Ojo TK (2022) Monkeypox: A Review of Clinical Features, Diagnosis, and Treatment. Cureus 14:e26756","journal-title":"Cureus"},{"key":"1469_CR30","doi-asserted-by":"publisher","first-page":"103816","DOI":"10.1016\/j.micpath.2019.103816","volume":"138","author":"S Chen","year":"2020","unstructured":"Chen S, Fang T, Xiao S, Lin F, Cheng X, Wang S, Zhu X, Chen X, Zheng M, Munir M, Huang M, Yu F, Chen S (2020) Duckling short beak and dwarfism syndrome virus infection activates host innate immune response involving both DNA and RNA sensors. Microb Pathog 138:103816","journal-title":"Microb Pathog"},{"key":"1469_CR31","doi-asserted-by":"publisher","first-page":"ltad020","DOI":"10.1093\/immadv\/ltad020","volume":"3","author":"MM Christodoulidou","year":"2023","unstructured":"Christodoulidou MM, Mabbott NA (2023) Efficacy of smallpox vaccines against Mpox infections in humans. Immunother Adv 3:ltad020","journal-title":"Immunother Adv"},{"key":"1469_CR32","doi-asserted-by":"crossref","unstructured":"Cohn H, Bloom N, Cai G, Clark J, Tarke A, Berm\u00fadez-Gonz\u00e1lez MC, Altman D, Lugo LA, Lobo FP, Marquez S, Chen J-Q, Ren W, Qin L, Crotty S, Krammer F, Grifoni A, Sette A, Simon V, Coelho CH (2023) Mpox vaccine and infection-driven human immune signatures. openRxiv","DOI":"10.1101\/2023.03.07.23286701"},{"key":"1469_CR33","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s41541-024-01052-2","volume":"9","author":"CA Cotter","year":"2024","unstructured":"Cotter CA, Ignacio MA, Americo JL, Earl PL, Mucker EM, Frey TR, Carfi A, Hooper JW, Freyn AW, Moss B (2024) Mpox mRNA-1769 vaccine inhibits orthopoxvirus replication at intranasal, intrarectal, and cutaneous sites of inoculation. npj Vaccines 9:256","journal-title":"npj Vaccines"},{"key":"1469_CR34","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/vaccines14030202","volume":"14","author":"Y Cui","year":"2026","unstructured":"Cui Y, Liang Z, Cong H (2026) From Design to Clinical Use: mRNA Vaccines for Infectious Diseases and Cancer. Vaccines 14:202","journal-title":"Vaccines"},{"key":"1469_CR35","doi-asserted-by":"crossref","unstructured":"Davies L, B\u00e4hner F, Faust SN, Blokhina O, Brandon D, Smith WB, Chatterjee VKK, Hassanin H, Babu TM, Zuiani A, M\u00fcller T, Poran A, Brittain C, Hooper JW, Mucker E, van der Most RG, Alonso P, Mensa F (2026) 219. Safety and Immunogenicity of BNT166a, an Investigational Quadrivalent mRNA Mpox Vaccine. Open Forum Infect Dis 13","DOI":"10.1093\/ofid\/ofaf695.077"},{"key":"1469_CR36","doi-asserted-by":"crossref","unstructured":"Evers MJW, Kulkarni JA, van der Meel R, Cullis PR, Vader P, Schiffelers RM (2018) State-of\u2010the\u2010art design and rapid\u2010mixing production techniques of lipid nanoparticles for nucleic acid delivery. Small Methods 2","DOI":"10.1002\/smtd.201700375"},{"key":"1469_CR37","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41422-023-00792-5","volume":"33","author":"Z Fang","year":"2023","unstructured":"Fang Z, Monteiro VS, Renauer PA, Shang X, Suzuki K, Ling X, Bai M, Xiang Y, Levchenko A, Booth CJ, Lucas C, Chen S (2023) Polyvalent mRNA vaccination elicited potent immune response to monkeypox virus surface antigens. Cell Res 33:407\u2013410","journal-title":"Cell Res"},{"key":"1469_CR38","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.3390\/v14112531","volume":"14","author":"J Fantini","year":"2022","unstructured":"Fantini J, Chahinian H, Yahi N (2022) A Vaccine Strategy Based on the Identification of an Annular Ganglioside Binding Motif in Monkeypox Virus Protein E8L. Viruses 14:2531","journal-title":"Viruses"},{"key":"1469_CR39","doi-asserted-by":"publisher","first-page":"1900101","DOI":"10.1002\/advs.201900101","volume":"6","author":"X Feng","year":"2019","unstructured":"Feng X, Xu W, Li Z, Song W, Ding J, Chen X (2019) Immunomodulatory Nanosystems. Adv Sci (Weinh) 6:1900101","journal-title":"Adv Sci (Weinh)"},{"key":"1469_CR40","doi-asserted-by":"crossref","unstructured":"Freyn AW, Atyeo C, Earl PL, Americo JL, Chuang G-Y, Natarajan H, Frey T, Gall J, Moliva JI, Hunegnaw R, Arunkumar GA, Ogega C, Nasir A, Bennett H, Johnson J, Durney MA, Stewart-Jones G, Hooper JW, Colpitts T, Alter G, Sullivan NJ, Carfi A, Moss B (2022) A monkeypox mRNA-lipid nanoparticle vaccine targeting virus binding, entry, and transmission drives protection against lethal orthopoxviral challenge. openRxiv","DOI":"10.1101\/2022.12.17.520886"},{"key":"1469_CR41","doi-asserted-by":"publisher","first-page":"eadg3540","DOI":"10.1126\/scitranslmed.adg3540","volume":"15","author":"AW Freyn","year":"2023","unstructured":"Freyn AW, Atyeo C, Earl PL, Americo JL, Chuang GY, Natarajan H, Frey TR, Gall JG, Moliva JI, Hunegnaw R, Asthagiri Arunkumar G, Ogega CO, Nasir A, Santos G, Levin RH, Meni A, Jorquera PA, Bennett H, Johnson JA, Durney MA, Stewart-Jones G, Hooper JW, Colpitts TM, Alter G, Sullivan NJ, Carfi A, Moss B (2023) An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge. Sci Transl Med 15:eadg3540","journal-title":"Sci Transl Med"},{"key":"1469_CR42","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12985-022-01935-7","volume":"19","author":"O Gholizadeh","year":"2022","unstructured":"Gholizadeh O, Yasamineh S, Amini P, Afkhami H, Delarampour A, Akbarzadeh S, Karimi Matloub R, Zahedi M, Hosseini P, Hajiesmaeili M, Poortahmasebi V (2022) Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview. Virol J 19:206","journal-title":"Virol J"},{"key":"1469_CR43","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.3390\/ijms24032700","volume":"24","author":"V Gote","year":"2023","unstructured":"Gote V, Bolla PK, Kommineni N, Butreddy A, Nukala PK, Palakurthi SS, Khan W (2023) A Comprehensive Review of mRNA Vaccines. Int J Mol Sci 24:2700","journal-title":"Int J Mol Sci"},{"key":"1469_CR44","doi-asserted-by":"publisher","first-page":"589959","DOI":"10.3389\/fchem.2020.589959","volume":"8","author":"ML Guevara","year":"2020","unstructured":"Guevara ML, Persano F, Persano S (2020) Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy. Front Chem 8:589959","journal-title":"Front Chem"},{"key":"1469_CR45","doi-asserted-by":"publisher","first-page":"150733","DOI":"10.1016\/j.ijbiomac.2026.150733","volume":"347","author":"A Gupta","year":"2026","unstructured":"Gupta A, Mittal P, Srivastva P, Chaudhary R, Singh A, Kumar S, Ramachandran R, Shrivastava T (2026) MPXV protein scaffold cum antigen-based macromolecular multi-antigen displaying next-generation vaccine, providing coordinated humoral and cellular response. Int J Biol Macromol 347:150733","journal-title":"Int J Biol Macromol"},{"key":"1469_CR46","doi-asserted-by":"publisher","first-page":"1547025","DOI":"10.3389\/fbioe.2025.1547025","volume":"13","author":"D Haghmorad","year":"2025","unstructured":"Haghmorad D, Eslami M, Orooji N, Halabitska I, Kamyshna I, Kamyshnyi O, Oksenych V (2025) mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy. Front Bioeng Biotechnol 13:1547025","journal-title":"Front Bioeng Biotechnol"},{"key":"1469_CR47","doi-asserted-by":"publisher","first-page":"114416","DOI":"10.1016\/j.addr.2022.114416","volume":"188","author":"C Hald Albertsen","year":"2022","unstructured":"Hald Albertsen C, Kulkarni JA, Witzigmann D, Lind M, Petersson K, Simonsen JB (2022) The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Adv Drug Deliv Rev 188:114416","journal-title":"Adv Drug Deliv Rev"},{"key":"1469_CR48","doi-asserted-by":"publisher","first-page":"7233","DOI":"10.1038\/s41467-021-27493-0","volume":"12","author":"X Han","year":"2021","unstructured":"Han X, Zhang H, Butowska K, Swingle KL, Alameh MG, Weissman D, Mitchell MJ (2021) An ionizable lipid toolbox for RNA delivery. Nat Commun 12:7233","journal-title":"Nat Commun"},{"key":"1469_CR49","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jconrel.2021.05.021","volume":"335","author":"KJ Hassett","year":"2021","unstructured":"Hassett KJ, Higgins J, Woods A, Levy B, Xia Y, Hsiao CJ, Acosta E, Almarsson O, Moore MJ, Brito LA (2021) Impact of lipid nanoparticle size on mRNA vaccine immunogenicity. J Control Release 335:237\u2013246","journal-title":"J Control Release"},{"key":"1469_CR50","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1002\/ejhf.2669","volume":"24","author":"B Heidecker","year":"2022","unstructured":"Heidecker B, Dagan N, Balicer R, Eriksson U, Rosano G, Coats A, Tschope C, Kelle S, Poland GA, Frustaci A, Klingel K, Martin P, Hare JM, Cooper LT, Pantazis A, Imazio M, Prasad S, Luscher TF (2022) Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases. Eur J Heart Fail 24:2000\u20132018","journal-title":"Eur J Heart Fail"},{"key":"1469_CR51","doi-asserted-by":"crossref","unstructured":"Hellgren F, Rosdahl A, Arcoverde Cerveira R, Lenart K, Ols S, Gwon YD, Kurt S, Delis AM, Joas G, Evander M, Normark J, Ahlm C, Forsell MN, Cajander S, Lore K (2024) Modulation of innate immune response to mRNA vaccination after SARS-CoV-2 infection or sequential vaccination in humans. JCI Insight 9","DOI":"10.1172\/jci.insight.175401"},{"key":"1469_CR52","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","volume":"78","author":"JW Hooper","year":"2004","unstructured":"Hooper JW, Thompson E, Wilhelmsen C, Zimmerman M, Ichou MA, Steffen SE, Schmaljohn CS, Schmaljohn AL, Jahrling PB (2004) Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox. J Virol 78:4433\u20134443","journal-title":"J Virol"},{"key":"1469_CR54","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou X, Zaks T, Langer R, Dong Y (2021) Lipid nanoparticles for mRNA delivery. Nat Rev Mater 6:1078\u20131094","journal-title":"Nat Rev Mater"},{"key":"1469_CR53","doi-asserted-by":"crossref","unstructured":"Hou F, Zhang Y, Liu X, Murad Y, Xu J, Yu Z, Hua X, Song Y, Ding J, Huang H, Zhao R, Jia W, Yang X (2022) Novel mRNA vaccines encoding Monkeypox virus M1R and A35R protect mice from a lethal virus challenge. openRxiv","DOI":"10.1101\/2022.11.19.517190"},{"key":"1469_CR55","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1007\/s00705-021-05152-5","volume":"166","author":"J Hu","year":"2021","unstructured":"Hu J, Stojanovic J, Yasamineh S, Yasamineh P, Karuppannan SK, Hussain Dowlath MJ, Serati-Nouri H (2021) The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection. Arch Virol 166:2649\u20132672","journal-title":"Arch Virol"},{"key":"1469_CR56","doi-asserted-by":"publisher","first-page":"e35086","DOI":"10.1371\/journal.pone.0035086","volume":"7","author":"PN Hudson","year":"2012","unstructured":"Hudson PN, Self J, Weiss S, Braden Z, Xiao Y, Girgis NM, Emerson G, Hughes C, Sammons SA, Isaacs SN, Damon IK, Olson VA (2012) Elucidating the role of the complement control protein in monkeypox pathogenicity. PLoS ONE 7:e35086","journal-title":"PLoS ONE"},{"key":"1469_CR57","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3390\/biomedicines13061439","volume":"13","author":"MA Izhari","year":"2025","unstructured":"Izhari MA, Alharthi SB, Alharbi RA, Almontasheri AHA, Alghamdi WA, Sindi AAA, Salem AA, Mahzari A, Alghamdi F, Gosady ARA (2025) Design and Validation of a Multi-Epitope mRNA Vaccine Construct Against Human Monkeypox Virus (hMPXV) by Annotating Protein of Intracellular Mature Virus (IMV) Form of hMPXV. Biomedicines 13:1439","journal-title":"Biomedicines"},{"key":"1469_CR58","doi-asserted-by":"publisher","first-page":"eadl4317","DOI":"10.1126\/scitranslmed.adl4317","volume":"16","author":"C Jacob-Dolan","year":"2024","unstructured":"Jacob-Dolan C, Ty D, Hope D, McMahan K, Liu J, Powers OC, Cotter CA, Sciacca M, Wu C, Borducchi E, Bouffard E, Richter H, Velasco J, Teow E, Boursiquot M, Cook A, Feliciano K, Yalley-Ogunro J, Seaman MS, Pessiant L, Lewis MG, Andersen H, Moss B, Barouch DH (2024) Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques. Sci Transl Med 16:eadl4317","journal-title":"Sci Transl Med"},{"key":"1469_CR59","doi-asserted-by":"crossref","unstructured":"Jacobs-Lorena M, Cha S-J (2024) Unbiased phage display screening identifies hidden malaria vaccine targets. Emerg Microbes Infections 13","DOI":"10.1080\/22221751.2024.2429617"},{"key":"1469_CR60","doi-asserted-by":"publisher","first-page":"104714","DOI":"10.1016\/j.idnow.2023.104714","volume":"53","author":"S Jamard","year":"2023","unstructured":"Jamard S, Handala L, Faussat C, Vincent N, Stefic K, Gaudy-Graffin C, Maakaroun-Vermesse Z, Lemaignen A (2023) Resurgence of symptomatic Mpox among vaccinated patients: First clues from a new-onset local cluster. Infect Dis Now 53:104714","journal-title":"Infect Dis Now"},{"key":"1469_CR61","doi-asserted-by":"crossref","unstructured":"Jiang H (2025) Application and Development of Structural Vaccinology in Vaccine Molecular Design Steps. In Proceedings of the 1st International Conference on Biomedical Engineering and Food Science, pp 198\u2013202. SCITEPRESS - Science and Technology Publications","DOI":"10.5220\/0014446300004933"},{"key":"1469_CR62","doi-asserted-by":"publisher","first-page":"106893","DOI":"10.1016\/j.compbiomed.2023.106893","volume":"159","author":"Y Jin","year":"2023","unstructured":"Jin Y, Fayyaz A, Liaqat A, Khan A, Alshammari A, Wang Y, Gu RX, Wei DQ (2023) Proteomics-based vaccine targets annotation and design of subunit and mRNA-based vaccines for Monkeypox virus (MPXV) against the recent outbreak. Comput Biol Med 159:106893","journal-title":"Comput Biol Med"},{"key":"1469_CR63","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12951-022-01478-7","volume":"20","author":"SH Kiaie","year":"2022","unstructured":"Kiaie SH, Majidi Zolbanin N, Ahmadi A, Bagherifar R, Valizadeh H, Kashanchi F, Jafari R (2022) Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects. J Nanobiotechnol 20:276","journal-title":"J Nanobiotechnol"},{"key":"1469_CR64","doi-asserted-by":"publisher","first-page":"21232","DOI":"10.1038\/s41598-022-25134-0","volume":"12","author":"CS Korosec","year":"2022","unstructured":"Korosec CS, Farhang-Sardroodi S, Dick DW, Gholami S, Ghaemi MS, Moyles IR, Craig M, Ooi HK, Heffernan JM (2022) Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex. Sci Rep 12:21232","journal-title":"Sci Rep"},{"key":"1469_CR65","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","volume":"55","author":"Y Lee","year":"2023","unstructured":"Lee Y, Jeong M, Park J, Jung H, Lee H (2023) Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics. Exp Mol Med 55:2085\u20132096","journal-title":"Exp Mol Med"},{"key":"1469_CR66","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12985-025-02645-6","volume":"22","author":"KY Leong","year":"2025","unstructured":"Leong KY, Tham SK, Poh CL (2025) Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications. Virol J 22:71","journal-title":"Virol J"},{"key":"1469_CR68","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41392-023-01574-6","volume":"8","author":"E Li","year":"2023","unstructured":"Li E, Guo X, Hong D, Gong Q, Xie W, Li T, Wang J, Chuai X, Chiu S (2023) Duration of humoral immunity from smallpox vaccination and its cross-reaction with Mpox virus. Signal Transduct Target Ther 8:350","journal-title":"Signal Transduct Target Ther"},{"key":"1469_CR67","doi-asserted-by":"publisher","first-page":"105974","DOI":"10.1016\/j.antiviral.2024.105974","volume":"230","author":"E Li","year":"2024","unstructured":"Li E, Gong Q, Zhang J, Guo X, Xie W, Chen D, Shen Y, Hong D, Li Z, Wang Q, Wang C, Wang Y, Chiu S (2024) An mpox quadrivalent mRNA vaccine protects mice from lethal vaccinia virus challenge. Antiviral Res 230:105974","journal-title":"Antiviral Res"},{"key":"1469_CR69","doi-asserted-by":"publisher","first-page":"7373","DOI":"10.1038\/s41467-025-61699-w","volume":"16","author":"Y Li","year":"2025","unstructured":"Li Y, Cheng L, Jiang L, Li Z, Rao J, Wu T, Zhang F, Xie B, He Y, Wang L, Zhang Z, Chen S (2025) A multivalent mRNA vaccine elicits robust immune responses and confers protection in a murine model of monkeypox virus infection. Nat Commun 16:7373","journal-title":"Nat Commun"},{"key":"1469_CR70","doi-asserted-by":"publisher","first-page":"e86981","DOI":"10.2196\/86981","volume":"12","author":"Y Liu","year":"2026","unstructured":"Liu Y, Jia Y, Li H, Ge J, Han Y, Xie Z, Chen J (2026) Knowledge, Attitudes, Practices, and Vaccination Willingness Toward Mpox (Monkeypox) Among Chinese Medical Students: Cross-Sectional Study. JMIR Public Health Surveillance 12:e86981\u2013e86981","journal-title":"JMIR Public Health Surveillance"},{"key":"1469_CR71","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.tips.2022.10.005","volume":"44","author":"JM Lozano","year":"2023","unstructured":"Lozano JM, Muller S (2023) Monkeypox: potential vaccine development strategies. Trends Pharmacol Sci 44:15\u201319","journal-title":"Trends Pharmacol Sci"},{"key":"1469_CR72","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12929-024-01080-z","volume":"31","author":"RM Lu","year":"2024","unstructured":"Lu RM, Hsu HE, Perez S, Kumari M, Chen GH, Hong MH, Lin YS, Liu CH, Ko SH, Concio CAP, Su YJ, Chang YH, Li WS, Wu HC (2024) Current landscape of mRNA technologies and delivery systems for new modality therapeutics. J Biomed Sci 31:89","journal-title":"J Biomed Sci"},{"key":"1469_CR73","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41577-022-00775-4","volume":"22","author":"FM Lum","year":"2022","unstructured":"Lum FM, Torres-Ruesta A, Tay MZ, Lin RTP, Lye DC, Renia L, Ng LFP (2022) Monkeypox: disease epidemiology, host immunity and clinical interventions. Nat Rev Immunol 22:597\u2013613","journal-title":"Nat Rev Immunol"},{"key":"1469_CR74","doi-asserted-by":"publisher","first-page":"110764","DOI":"10.1016\/j.compbiomed.2025.110764","volume":"196","author":"N Maghsoodi","year":"2025","unstructured":"Maghsoodi N, Nezafat N, Ramezani A (2025) Computational design of a multi-epitope mRNA vaccine against orthopoxviruses: A path toward comprehensive poxvirus protection. Comput Biol Med 196:110764","journal-title":"Comput Biol Med"},{"key":"1469_CR75","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1016\/j.vaccine.2009.03.040","volume":"27","author":"JF Mann","year":"2009","unstructured":"Mann JF, Shakir E, Carter KC, Mullen AB, Alexander J, Ferro VA (2009) Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1\/Th2 bias in the immune response and protection against infection. Vaccine 27:3643\u20133649","journal-title":"Vaccine"},{"key":"1469_CR76","doi-asserted-by":"crossref","unstructured":"Marh\u00e1nkov\u00e1 JH, Kotherov\u00e1 Z, Numerato D (2024) Navigating vaccine hesitancy: Strategies and dynamics in healthcare professional-parent communication. Hum Vaccines Immunotherapeutics 20","DOI":"10.1080\/21645515.2024.2361943"},{"key":"1469_CR77","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.3390\/vaccines11101541","volume":"11","author":"G Matusali","year":"2023","unstructured":"Matusali G, Petruccioli E, Cimini E, Colavita F, Bettini A, Tartaglia E, Sbarra S, Meschi S, Lapa D, Francalancia M, Bordi L, Mazzotta V, Coen S, Mizzoni K, Beccacece A, Nicastri E, Pierelli L, Antinori A, Girardi E, Vaia F, Sette A, Grifoni A, Goletti D, Puro V, Maggi F (2023) Evaluation of Cross-Immunity to the Mpox Virus Due to Historic Smallpox Vaccination. Vaccines (Basel) 11:1541","journal-title":"Vaccines (Basel)"},{"key":"1469_CR78","doi-asserted-by":"publisher","first-page":"e0150421","DOI":"10.1128\/JVI.01504-21","volume":"96","author":"EM Mucker","year":"2022","unstructured":"Mucker EM, Golden JW, Hammerbeck CD, Kishimori JM, Royals M, Joselyn MD, Ballantyne J, Nalca A, Hooper JW (2022) A Nucleic Acid-Based Orthopoxvirus Vaccine Targeting the Vaccinia Virus L1, A27, B5, and A33 Proteins Protects Rabbits against Lethal Rabbitpox Virus Aerosol Challenge. J Virol 96:e0150421","journal-title":"J Virol"},{"key":"1469_CR79","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3390\/vaccines10050713","volume":"10","author":"AY Nadeem","year":"2022","unstructured":"Nadeem AY, Shehzad A, Islam SU, Al-Suhaimi EA, Lee YS (2022) Mosquirix\u2122 RTS, S\/AS01 Vaccine Development, Immunogenicity, and Efficacy. Vaccines 10:713","journal-title":"Vaccines"},{"key":"1469_CR80","doi-asserted-by":"publisher","first-page":"127598","DOI":"10.1016\/j.vaccine.2025.127598","volume":"62","author":"E Ortiz-Prado","year":"2025","unstructured":"Ortiz-Prado E, Kyriakidis NC, L\u00f3pez-Cort\u00e9s A, Vasconez-Gonzalez J, Suarez I, Pazmi\u00f1o-Almeida J, Barriga-Collantes M, Cadena MP, Reascos-Arteaga M, Acosta-Mu\u00f1oz E, Acosta-Mu\u00f1oz MC, Villarreal K, Izquierdo-Condoy JS (2025) Current and emerging Mpox vaccine strategies: A comprehensive review. Vaccine 62:127598","journal-title":"Vaccine"},{"key":"1469_CR81","doi-asserted-by":"publisher","first-page":"101403","DOI":"10.1016\/j.nantod.2022.101403","volume":"43","author":"M Papi","year":"2022","unstructured":"Papi M, Pozzi D, Palmieri V, Caracciolo G (2022) Principles for optimization and validation of mRNA lipid nanoparticle vaccines against COVID-19 using 3D bioprinting. Nano Today 43:101403","journal-title":"Nano Today"},{"key":"1469_CR82","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi N, Hogan MJ, Porter FW, Weissman D (2018) mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discov 17:261\u2013279","journal-title":"Nat Rev Drug Discov"},{"key":"1469_CR83","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","volume":"23","author":"K Paunovska","year":"2022","unstructured":"Paunovska K, Loughrey D, Dahlman JE (2022) Drug delivery systems for RNA therapeutics. Nat Rev Genet 23:265\u2013280","journal-title":"Nat Rev Genet"},{"key":"1469_CR84","doi-asserted-by":"publisher","first-page":"126053","DOI":"10.1016\/j.vaccine.2024.06.021","volume":"42","author":"L Pischel","year":"2024","unstructured":"Pischel L, Martini BA, Yu N, Cacesse D, Tracy M, Kharbanda K, Ahmed N, Patel KM, Grimshaw AA, Malik AA, Goshua G, Omer SB (2024) Vaccine effectiveness of 3rd generation mpox vaccines against mpox and disease severity: A systematic review and meta-analysis. Vaccine 42:126053","journal-title":"Vaccine"},{"key":"1469_CR85","first-page":"191","volume":"42","author":"E Prompetchara","year":"2024","unstructured":"Prompetchara E, Ketloy C, Khawsang C, Palaga T, Ruxrungtham K (2024) Mpox global health emergency: Insights into the virus, immune responses, and advancements in vaccines PART II: Insights into the advancements in vaccines. Asian Pac J Allergy Immunol 42:191\u2013206","journal-title":"Asian Pac J Allergy Immunol"},{"key":"1469_CR86","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10930-023-10150-4","volume":"42","author":"SV Ramprasadh","year":"2023","unstructured":"Ramprasadh SV, Rajakumar S, Srinivasan S, Susha D, Sharma S, Chourasiya R (2023) Computer-Aided Multi-Epitope Based Vaccine Design Against Monkeypox Virus Surface Protein A30L: An Immunoinformatics Approach. Protein J 42:645\u2013663","journal-title":"Protein J"},{"key":"1469_CR87","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3390\/v15051120","volume":"15","author":"N Rcheulishvili","year":"2023","unstructured":"Rcheulishvili N, Mao J, Papukashvili D, Feng S, Liu C, Yang X, Lin J, He Y, Wang PG (2023) Development of a Multi-Epitope Universal mRNA Vaccine Candidate for Monkeypox, Smallpox, and Vaccinia Viruses: Design and In Silico Analyses. Viruses 15:1120","journal-title":"Viruses"},{"key":"1469_CR88","first-page":"305","volume":"160","author":"J Reina","year":"2023","unstructured":"Reina J, Iglesias C (2023) Vaccines against monkeypox. Med Clin (Engl Ed) 160:305\u2013309","journal-title":"Med Clin (Engl Ed)"},{"key":"1469_CR89","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.tim.2011.12.001","volume":"20","author":"MG Reynolds","year":"2012","unstructured":"Reynolds MG, Damon IK (2012) Outbreaks of human monkeypox after cessation of smallpox vaccination. Trends Microbiol 20:80\u201387","journal-title":"Trends Microbiol"},{"key":"1469_CR90","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1016\/j.vaccine.2023.04.010","volume":"41","author":"RL Roper","year":"2023","unstructured":"Roper RL, Garzino-Demo A, Del Rio C, Brechot C, Gallo R, Hall W, Esparza J, Reitz M, Schinazi RF, Parrington M, Tartaglia J, Koopmans M, Osorio J, Nitsche A, Huan TB, LeDuc J, Gessain A, Weaver S, Mahalingam S, Abimiku A, Vahlne A, Segales J, Wang L, Isaacs SN, Osterhaus A, Scheuermann RH, McFadden G (2023) Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies. Vaccine 41:3171\u20133177","journal-title":"Vaccine"},{"key":"1469_CR92","doi-asserted-by":"crossref","unstructured":"Sang Y, Zhang Z, Liu F, Lu H, Yu C, Sun H, Long J, Cao Y, Mai J, Wang X, Fang J, Wang Y, Huang W, Yang J, Wang S (2022) Monkeypox virus quadrivalent mRNA vaccine induces antibody responses and cellular immunity and protects mice against Vaccinia virus. openRxiv","DOI":"10.1101\/2022.11.22.517500"},{"key":"1469_CR91","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41392-023-01432-5","volume":"8","author":"Y Sang","year":"2023","unstructured":"Sang Y, Zhang Z, Liu F, Lu H, Yu C, Sun H, Long J, Cao Y, Mai J, Miao Y, Wang X, Fang J, Wang Y, Huang W, Yang J, Wang S (2023) Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus. Signal Transduct Target Ther 8:172","journal-title":"Signal Transduct Target Ther"},{"key":"1469_CR93","doi-asserted-by":"publisher","first-page":"120586","DOI":"10.1016\/j.ijpharm.2021.120586","volume":"601","author":"L Schoenmaker","year":"2021","unstructured":"Schoenmaker L, Witzigmann D, Kulkarni JA, Verbeke R, Kersten G, Jiskoot W, Crommelin DJA (2021) mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability. Int J Pharm 601:120586","journal-title":"Int J Pharm"},{"key":"1469_CR94","doi-asserted-by":"crossref","unstructured":"Shafaati M, Forghani S, Shahsavand Davoudi A, Samiee R, Mohammadi K, Akbarpour S, Seifi A, Salehi M, Zare M (2025) Current advances and challenges in mpox vaccine development: a global landscape. Therapeutic Adv Vaccines Immunotherapy 13","DOI":"10.1177\/25151355251314339"},{"key":"1469_CR95","doi-asserted-by":"publisher","first-page":"43341","DOI":"10.1021\/acsomega.3c07866","volume":"8","author":"M Shah","year":"2023","unstructured":"Shah M, Jaan S, Shehroz M, Sarfraz A, Asad K, Wara TU, Zaman A, Ullah R, Ali EA, Nishan U, Ojha SC (2023) Deciphering the Immunogenicity of Monkeypox Proteins for Designing the Potential mRNA Vaccine. ACS Omega 8:43341\u201343355","journal-title":"ACS Omega"},{"key":"1469_CR96","doi-asserted-by":"publisher","first-page":"106112","DOI":"10.1016\/j.antiviral.2025.106112","volume":"236","author":"C Shang","year":"2025","unstructured":"Shang C, Chen M, Liu Y, Li X, Li Y (2025) Defining diabetic mouse as a highly susceptible preclinical model for monkeypox virus infection. Antiviral Res 236:106112","journal-title":"Antiviral Res"},{"key":"1469_CR97","doi-asserted-by":"publisher","first-page":"101487","DOI":"10.1016\/j.nmni.2024.101487","volume":"62","author":"P Singh","year":"2024","unstructured":"Singh P, Sridhar SB, Shareef J, Talath S, Mohapatra P, Khatib MN, Ballal S, Kaur M, Nathiya D, Sharma S, Siva Prasad GV, Sinha A, Varma A, Bushi G, Gaidhane AM, Satapathy P, Shabil M, Sah R, Al-Tawfiq JA, Sah R, Rodriguez-Morales AJ (2024) The resurgence of monkeypox: Epidemiology, clinical features, and public health implications in the post-smallpox eradication era. New Microbes New Infect 62:101487","journal-title":"New Microbes New Infect"},{"key":"1469_CR99","doi-asserted-by":"crossref","unstructured":"Su C, Wen Y, Geng X, Yang C, Yin Q, Xiong Y, Liu Z (2023a) A Quadrivalent mRNA immunization elicits potent immune responses against vaccinia and monkeypox viral antigens \u2013 a step closer to a broad orthopoxvirus vaccine. openRxiv","DOI":"10.1101\/2023.04.23.537951"},{"key":"1469_CR100","doi-asserted-by":"publisher","first-page":"1172000","DOI":"10.3389\/fimmu.2023.1172000","volume":"14","author":"CM Su","year":"2023","unstructured":"Su CM, Du Y, Rowland RRR, Wang Q, Yoo D (2023b) Reprogramming viral immune evasion for a rational design of next-generation vaccines for RNA viruses. Front Immunol 14:1172000","journal-title":"Front Immunol"},{"key":"1469_CR98","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3390\/vaccines12040385","volume":"12","author":"C Su","year":"2024","unstructured":"Su C, Li S, Wen Y, Geng X, Yin Q, Wang Y, Xiong Y, Liu Z (2024) A Quadrivalent mRNA Immunization Elicits Potent Immune Responses against Multiple Orthopoxviral Antigens and Neutralization of Monkeypox Virus in Rodent Models. Vaccines (Basel) 12:385","journal-title":"Vaccines (Basel)"},{"key":"1469_CR101","doi-asserted-by":"crossref","unstructured":"Sun J (2025) Research Advances in mRNA Vaccine Manufacturing Processes. In Proceedings of the 1st International Conference on Biomedical Engineering and Food Science, pp 458\u2013464. SCITEPRESS - Science and Technology Publications","DOI":"10.5220\/0014499200004933"},{"key":"1469_CR102","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/pathogens10010006","volume":"10","author":"CD Suraweera","year":"2020","unstructured":"Suraweera CD, Hinds MG, Kvansakul M (2020) Poxviral Strategies to Overcome Host Cell Apoptosis. Pathogens 10:6","journal-title":"Pathogens"},{"key":"1469_CR103","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3390\/vaccines11030658","volume":"11","author":"K Swetha","year":"2023","unstructured":"Swetha K, Kotla NG, Tunki L, Jayaraj A, Bhargava SK, Hu H, Bonam SR, Kurapati R (2023) Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines. Vaccines (Basel) 11:658","journal-title":"Vaccines (Basel)"},{"key":"1469_CR104","doi-asserted-by":"crossref","unstructured":"Tai W, Tian C, Shi H, Chai B, Yu X, Zhuang X, Dong P, Li M, Yin Q, Feng S, Wang W, Zhang O, Liang S, Liu Y, Liu J, Zhu L, Zhao G, Tian M, Yu G, Cheng G (2025) An mRNA vaccine against monkeypox virus inhibits infection by co-activation of humoral and cellular immune responses. Nat Commun 16","DOI":"10.1038\/s41467-025-58328-x"},{"key":"1469_CR107","doi-asserted-by":"publisher","first-page":"1112816","DOI":"10.3389\/fimmu.2023.1112816","volume":"14","author":"C Tan","year":"2023","unstructured":"Tan C, Zhu F, Pan P, Wu A, Li C (2023) Development of multi-epitope vaccines against the monkeypox virus based on envelope proteins using immunoinformatics approaches. Front Immunol 14:1112816","journal-title":"Front Immunol"},{"key":"1469_CR105","doi-asserted-by":"publisher","first-page":"9247","DOI":"10.1080\/07391102.2024.2325109","volume":"43","author":"C Tan","year":"2024","unstructured":"Tan C, Zhou J, Wu A, Li C (2024) In silico development of a novel anti-mutation, multi-epitope mRNA vaccine against MPXV variants of emerging lineage and sub-lineages by using immunoinformatics approaches. J Biomol Struct Dynamics 43:9247\u20139264","journal-title":"J Biomol Struct Dynamics"},{"key":"1469_CR106","doi-asserted-by":"publisher","first-page":"9247","DOI":"10.1080\/07391102.2024.2325109","volume":"43","author":"C Tan","year":"2025","unstructured":"Tan C, Zhou J, Wu A, Li C (2025) In silico development of a novel anti-mutation, multi-epitope mRNA vaccine against MPXV variants of emerging lineage and sub-lineages by using immunoinformatics approaches. J Biomol Struct Dyn 43:9247\u20139264","journal-title":"J Biomol Struct Dyn"},{"key":"1469_CR108","doi-asserted-by":"crossref","unstructured":"Tang C, Yuan L, Xie Y, Yang Y, Zhou Y, Wang J, Yang H, Peng R, Xu J, Yu W, Huang Q, Quan W, Li B, Wang Y, Lu S (2026) An mRNA vaccine based on antigens from conserved regions of monkeypox virus A35R and M1R with a dimer-like conformation confers protection against both monkeypox virus and vaccinia virus infections in mice. MedComm 7","DOI":"10.1002\/mco2.70614"},{"key":"1469_CR109","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1021\/jacs.2c10670","volume":"145","author":"G Tilstra","year":"2023","unstructured":"Tilstra G, Couture-Senecal J, Lau YMA, Manning AM, Wong DSM, Janaeska WW, Wuraola TA, Pang J, Khan OF (2023) Iterative Design of Ionizable Lipids for Intramuscular mRNA Delivery. J Am Chem Soc 145:2294\u20132304","journal-title":"J Am Chem Soc"},{"key":"1469_CR110","doi-asserted-by":"crossref","unstructured":"Vemula D, Bhandari V (2026) Reverse Vaccinology and Immunoinformatics-Driven Design of a Multi-Epitope Vaccine Candidate Against Pseudomonas aeruginosa. Elsevier BV","DOI":"10.2139\/ssrn.6038223"},{"key":"1469_CR111","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","volume":"55","author":"R Verbeke","year":"2022","unstructured":"Verbeke R, Hogan MJ, Lore K, Pardi N (2022) Innate immune mechanisms of mRNA vaccines. Immunity 55:1993\u20132005","journal-title":"Immunity"},{"key":"1469_CR112","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.3390\/vaccines12101148","volume":"12","author":"J Wang","year":"2024","unstructured":"Wang J, Ding Y, Chong K, Cui M, Cao Z, Tang C, Tian Z, Hu Y, Zhao Y, Jiang S (2024) Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery. Vaccines (Basel) 12:1148","journal-title":"Vaccines (Basel)"},{"key":"1469_CR113","first-page":"69","volume":"12","author":"W Wang","year":"2025","unstructured":"Wang W, Li JX, Long SQ, Liu ZN, Li XP, Peng ZH, Zheng JD, Liao YH (2025) Emerging strategies for monkeypox: antigen and antibody applications in diagnostics, vaccines, and treatments. Mil Med Res 12:69","journal-title":"Mil Med Res"},{"key":"1469_CR114","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jiph.2022.12.023","volume":"16","author":"M Waqas","year":"2023","unstructured":"Waqas M, Aziz S, Bushra A, Halim SA, Ali A, Ullah S, Khalid A, Abdalla AN, Khan A, Al-Harrasi A (2023a) Employing an immunoinformatics approach revealed potent multi-epitope based subunit vaccine for lymphocytic choriomeningitis virus. J Infect Public Health 16:214\u2013232","journal-title":"J Infect Public Health"},{"key":"1469_CR115","doi-asserted-by":"publisher","first-page":"1091941","DOI":"10.3389\/fimmu.2023.1091941","volume":"14","author":"M Waqas","year":"2023","unstructured":"Waqas M, Aziz S, Lio P, Khan Y, Ali A, Iqbal A, Khan F, Almajhdi FN (2023b) Immunoinformatics design of multivalent epitope vaccine against monkeypox virus and its variants using membrane-bound, enveloped, and extracellular proteins as targets. Front Immunol 14:1091941","journal-title":"Front Immunol"},{"key":"1469_CR116","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41591-023-02229-3","volume":"29","author":"Y Wolff Sagy","year":"2023","unstructured":"Wolff Sagy Y, Zucker R, Hammerman A, Markovits H, Arieh NG, Abu Ahmad W, Battat E, Ramot N, Carmeli G, Mark-Amir A, Wagner-Kolasko G, Duskin-Bitan H, Yaron S, Peretz A, Arbel R, Lavie G, Netzer D (2023) Real-world effectiveness of a single dose of mpox vaccine in males. Nat Med 29:748\u2013752","journal-title":"Nat Med"},{"key":"1469_CR117","first-page":"99","volume":"16","author":"L Xie","year":"2025","unstructured":"Xie L, Zhou Y, Zhang X, Lan T, Sun W (2025) Global Trends in MPOX Research (2014\u20132025): A Bibliometric Analysis and Overview. Veterinary Medicine: Res Rep 16:99\u2013112","journal-title":"Veterinary Medicine: Res Rep"},{"key":"1469_CR118","doi-asserted-by":"crossref","unstructured":"Xu F, Huang Y, Hou Y, Xie Y, Huang B, Zhao F, Gao Z, Chen C, Wang J, Mei S, Hu Y, Wang L, Wei L, Zhang J, Li N, Cong Z, Ma J, Zhu L, Chen T, Lu J, Wei Q, Tan W, Xue J, Guo F (2025a) A new attenuated and highly immunogenic orthopoxvirus vaccine protects against mpox in mice and macaques. npj Vaccines 10","DOI":"10.1038\/s41541-025-01193-y"},{"key":"1469_CR119","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/vaccines13050514","volume":"13","author":"Q Xu","year":"2025","unstructured":"Xu Q, Zhang RR, Wu M, Zhang J, Wang ZX, Chi H, Zhou C, Xiong XC, Liu HT, Qin CF, Ye Q (2025b) A Single-Chain Mpox mRNA Vaccine Elicits Protective Immune Response in Mice. Vaccines (Basel) 13:514","journal-title":"Vaccines (Basel)"},{"key":"1469_CR120","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3390\/v17060753","volume":"17","author":"R Yadav","year":"2025","unstructured":"Yadav R, Chaudhary AA, Srivastava U, Gupta S, Rustagi S, Rudayni HA, Kashyap VK, Kumar S (2025) Mpox 2022 to 2025 Update: A Comprehensive Review on Its Complications, Transmission, Diagnosis, and Treatment. Viruses 17:753","journal-title":"Viruses"},{"key":"1469_CR121","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13287-022-02944-7","volume":"13","author":"S Yasamineh","year":"2022","unstructured":"Yasamineh S, Kalajahi HG, Yasamineh P, Gholizadeh O, Youshanlouei HR, Matloub SK, Mozafari M, Jokar E, Yazdani Y, Dadashpour M (2022a) Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19. Stem Cell Res Ther 13:257","journal-title":"Stem Cell Res Ther"},{"key":"1469_CR122","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1186\/s12951-022-01625-0","volume":"20","author":"S Yasamineh","year":"2022","unstructured":"Yasamineh S, Kalajahi HG, Yasamineh P, Yazdani Y, Gholizadeh O, Tabatabaie R, Afkhami H, Davodabadi F, Farkhad AK, Pahlevan D, Firouzi-Amandi A, Nejati-Koshki K, Dadashpour M (2022b) An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19. J Nanobiotechnol 20:440","journal-title":"J Nanobiotechnol"},{"key":"1469_CR123","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/fractalfract10010044","volume":"10","author":"M Yurto\u011flu","year":"2026","unstructured":"Yurto\u011flu M, Yap\u0131\u015fkan D, Bonyah E, \u0130skender Ero\u011flu BB, Avc\u0131 D, Torres DFM (2026) Dynamic Analysis and Optimal Prevention Strategies for Monkeypox Spread Modeled via the Mittag\u2013Leffler Kernel. Fractal Fract 10:44","journal-title":"Fractal Fract"},{"key":"1469_CR124","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-022-02090-w","volume":"29","author":"LM Zaeck","year":"2023","unstructured":"Zaeck LM, Lamers MM, Verstrepen BE, Bestebroer TM, van Royen ME, Gotz H, Shamier MC, van Leeuwen LPM, Schmitz KS, Alblas K, van Efferen S, Bogers S, Scherbeijn S, Rimmelzwaan GF, van Gorp ECM, Koopmans MPG, Haagmans BL, GeurtsvanKessel CH, de Vries RD (2023) Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals. Nat Med 29:270\u2013278","journal-title":"Nat Med"},{"key":"1469_CR125","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1038\/labinvest.3780373","volume":"81","author":"GM Zaucha","year":"2001","unstructured":"Zaucha GM, Jahrling PB, Geisbert TW, Swearengen JR, Hensley L (2001) The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis). Lab Invest 81:1581\u20131600","journal-title":"Lab Invest"},{"key":"1469_CR126","doi-asserted-by":"publisher","first-page":"2204151","DOI":"10.1080\/22221751.2023.2204151","volume":"12","author":"J Zeng","year":"2023","unstructured":"Zeng J, Li Y, Jiang L, Luo L, Wang Y, Wang H, Han X, Zhao J, Gu G, Fang M, Huang Q, Yan J (2023) Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge. Emerg Microbes Infect 12:2204151","journal-title":"Emerg Microbes Infect"},{"key":"1469_CR127","doi-asserted-by":"publisher","first-page":"2192815","DOI":"10.1080\/22221751.2023.2192815","volume":"12","author":"RR Zhang","year":"2023","unstructured":"Zhang RR, Wang ZJ, Zhu YL, Tang W, Zhou C, Zhao SQ, Wu M, Ming T, Deng YQ, Chen Q, Jin NY, Ye Q, Li X, Qin CF (2023) Rational development of multicomponent mRNA vaccine candidates against mpox. Emerg Microbes Infect 12:2192815","journal-title":"Emerg Microbes Infect"},{"key":"1469_CR128","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.cell.2024.01.017","volume":"187","author":"A Zuiani","year":"2024","unstructured":"Zuiani A, Dulberger CL, De Silva NS, Marquette M, Lu Y-J, Palowitch GM, Dokic A, Sanchez-Velazquez R, Schlatterer K, Sarkar S, Kar S, Chawla B, Galeev A, Lindemann C, Rothenberg DA, Diao H, Walls AC, Addona TA, Mensa F, Vogel AB, Stuart LM, van der Most R, Srouji JR, T\u00fcreci \u00d6, Gaynor RB, \u015eahin U, Poran A (2024a) A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease. Cell 187:1363\u20131373e1312","journal-title":"Cell"},{"key":"1469_CR129","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.cell.2024.01.017","volume":"187","author":"A De Zuiani","year":"2024","unstructured":"Zuiani A, Dulberger CL, De Silva NS, Marquette M, Lu YJ, Palowitch GM, Dokic A, Sanchez-Velazquez R, Schlatterer K, Sarkar S, Kar S, Chawla B, Galeev A, Lindemann C, Rothenberg DA, Diao H, Walls AC, Addona TA, Mensa F, Vogel AB, Stuart LM, van der Most R, Srouji JR, Tureci O, Gaynor RB, Sahin U, Poran A (2024b) A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease. Cell 187:1363\u20131373.e1312","journal-title":"Cell"},{"key":"1469_CR130","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3390\/vaccines13040374","volume":"13","author":"J Zuo","year":"2025","unstructured":"Zuo J, Wu J, Zhang Z, Long J, Yu C, Liao Y, Zhang H, Yang J (2025a) An Mpox Multi-Antigen-Tandem Bivalent mRNA Candidate Vaccine Effectively Protects Mice Against the Vaccinia Virus. Vaccines (Basel) 13:374","journal-title":"Vaccines (Basel)"},{"key":"1469_CR131","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3390\/vaccines13040374","volume":"13","author":"J Zuo","year":"2025","unstructured":"Zuo J, Wu J, Zhang Z, Long J, Yu C, Liao Y, Zhang H, Yang J (2025b) An Mpox Multi-Antigen-Tandem Bivalent mRNA Candidate Vaccine Effectively Protects Mice Against the Vaccinia Virus. Vaccines 13:374","journal-title":"Vaccines"}],"container-title":["Folia Microbiologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-026-01469-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12223-026-01469-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-026-01469-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T08:03:08Z","timestamp":1775462588000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12223-026-01469-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":131,"alternative-id":["1469"],"URL":"https:\/\/doi.org\/10.1007\/s12223-026-01469-3","relation":{},"ISSN":["0015-5632","1874-9356"],"issn-type":[{"value":"0015-5632","type":"print"},{"value":"1874-9356","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"20 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}